Navigating 21st Century Cures Act Palliative & Hospice Prior Authorization
The 21st Century Cures Act significantly reshapes how palliative & hospice prior authorization is managed, introducing mandates for electronic submissions and data exchange.
Revenue cycle directors and prior authorization coordinators in palliative and hospice settings face unique challenges in securing timely approvals for essential services and medications. The Cures Act's provisions aim to reduce administrative burden and improve patient access, but require a clear understanding of new operational requirements.
The Cures Act Mandate for Electronic Prior Authorization (ePA)
The 21st Century Cures Act, particularly through the CMS Interoperability and Patient Access Rule (CMS-0057-F), mandates specific payers to implement electronic prior authorization (ePA) processes. This includes Medicare Advantage (MA) plans, Medicaid managed care organizations (MCOs), and Children's Health Insurance Program (CHIP) MCOs, directly impacting PA for hospice levels of care, palliative medications, and durable medical equipment (DME).
Specific Impacts on Palliative & Hospice PA Workflows
For palliative and hospice providers, the Cures Act's ePA mandate necessitates a shift from traditional fax or portal-based submissions to structured electronic transactions. This affects critical PA categories such as hospice election, authorization for General Inpatient (GIP) level care, continuous home care, and high-volume palliative medications. The goal is to streamline the submission and approval process, reducing administrative delays.
Key Changes for Palliative & Hospice Providers Under the Cures Act
- Mandated electronic PA (ePA) for specific payers (MA, Medicaid MCOs, CHIP MCOs).
- Shorter turnaround times for certain PA requests as defined by CMS-0057-F.
- Enhanced access to patient data via FHIR-based APIs, reducing information blocking.
- Requirement for payers to provide reasons for denial and publicly report PA metrics.
- Potential for automated PA status updates and improved transparency.
Leveraging Interoperability for Efficient PA Documentation
The Cures Act's emphasis on interoperability, including standards like SMART on FHIR and frameworks such as Da Vinci PAS, is crucial for palliative and hospice care. These standards facilitate seamless data exchange between EMRs and payer systems, allowing for the automated submission of clinical documentation required for PA. This reduces manual data entry, minimizes errors, and accelerates the overall approval process for services like hospice levels of care or specific palliative treatments.
Preparing for Compliance and Streamlined Operations
To comply with the 21st Century Cures Act and optimize prior authorization for palliative and hospice services, organizations must ensure their systems can handle X12 278 transactions and integrate with FHIR-enabled payer APIs. This strategic shift towards automation not only addresses regulatory requirements but also significantly reduces administrative burden, allowing care teams to focus on patient care rather than paperwork. Discuss these operational considerations with your IT and compliance teams.
Frequently asked questions
What specific Cures Act provisions affect palliative and hospice prior authorization?
The primary impact stems from the CMS Interoperability and Patient Access Rule (CMS-0057-F), which mandates ePA for specific payers. Additionally, information blocking provisions ensure providers have access to necessary patient data for PA submissions.
Which payers are subject to the Cures Act's ePA mandates relevant to palliative and hospice care?
Medicare Advantage plans, Medicaid managed care organizations (MCOs), and Children's Health Insurance Program (CHIP) MCOs are required to implement ePA processes under the Cures Act, directly affecting PA for palliative and hospice services.
How does ePA specifically apply to hospice levels of care under the Cures Act?
The ePA mandate requires electronic submission for authorizations of hospice levels of care, including routine home care, continuous home care, inpatient respite care, and general inpatient (GIP) care, when dealing with mandated payers. This streamlines the justification and approval process for these critical services.
Will turnaround times for palliative medication prior authorizations change due to the Cures Act?
Yes, for prior authorizations submitted to mandated payers, the Cures Act (via CMS-0057-F) establishes specific, shorter turnaround timeframes for responses to ePA requests. This aims to expedite access to essential palliative medications.
What technology is needed to comply with Cures Act ePA requirements for palliative and hospice providers?
Compliance requires technology solutions capable of generating and exchanging X12 278 transactions and leveraging FHIR-based APIs for data exchange. Integration with EMRs and automated workflows are key to efficiently managing ePA for palliative and hospice services.
Related coverage
Ready to stay compliant with this rule?
See how Klivira automates prior authorizations for your team.
Request a demo